Absci — independent third-party profile of a public API surface, by API Evangelist. Absci is a Vancouver, Washington-based generative AI drug creation company (NASDAQ: ABSI) using AI and synthetic biology to design de novo antibodies in silico against specified epitopes.
synthetic-biology drug-discovery nasdaq biotechnology apis-json therapeutics foundation-models generative-ai antibody-design ai-for-biology de-novo-antibody-generation origin-1 integrated-drug-creation
-
Updated
Sep 4, 2026